Cargando…
Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study
Background - Stroke represents one of the most important causes of permanent physical or mental disability. A number of recent advances in recovery have reinforced the idea that pharmacological intervention combined with a specific rehabilitation therapy can reduce disability after stroke. Objective...
Autores principales: | Stan, A, Birle, C, Blesneag, A, Iancu, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771251/ https://www.ncbi.nlm.nih.gov/pubmed/29362596 |
Ejemplares similares
-
Efficacy and safety of Cerebrolysin treatment in early recovery
after acute ischemic stroke: a randomized, placebo-controlled,
double-blinded, multicenter clinical trial
por: Gharagozli, K, et al.
Publicado: (2017) -
Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Danfeng, et al.
Publicado: (2017) -
Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022) -
Neuroprotective and consequent neurorehabilitative clinical outcomes, in
patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009) -
Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
por: Wang, Zefeng, et al.
Publicado: (2017)